Rank;Global Rank;Institution;Country;Sector
1;185;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
2;228;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
3;292;AstraZeneca, United Kingdom;GBR;Companies
4;311;Hoffmann-La Roche Ltd, Switzerland;CHE;Companies
5;313;Philips Research, Eindhoven;NLD;Companies
6;359;Siemens AG, Germany;DEU;Companies
7;372;Novo Nordisk A/S;DNK;Companies
8;379;Danone Nederland BV;NLD;Companies
9;414;VTT Technical Research Centre of Finland;FIN;Companies
10;424;Merck KGaA, Germany;DEU;Companies
11;447;Sanofi, France;FRA;Companies
12;486;Janssen Research & Development, LLC;BEL;Companies
13;488;Bayer AG, Germany;DEU;Companies
14;554;AstraZeneca, Sweden;SWE;Companies
15;590;Boehringer Ingelheim GmbH Germany;DEU;Companies
16;600;Siemens Healthineers, Germany;DEU;Companies
17;622;Novartis, Switzerland;CHE;Companies
18;636;Nestle Switzerland;CHE;Companies
19;717;Sanofi Pasteur MSD, France;FRA;Companies
20;728;GlaxoSmithKline, United Kingdom;GBR;Companies
21;741;Bosch, Germany;DEU;Companies
22;933;UCB Pharma SA, Belgium;BEL;Companies
23;982;IMEC International;BEL;Companies
24;1116;Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique;FRA;Companies
25;1123;BASF, Germany;DEU;Companies
26;1292;GlaxoSmithKline, Belgium;BEL;Companies
27;1883;SINTEF Group;NOR;Companies
28;2144;Sanofi, Germany;DEU;Companies
29;2146;Pfizer Inc, United Kingdom;GBR;Companies